Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

124 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia.
Tefferi A, Li CY, Reeder CB, Geyer SM, Allmer C, Levitt R, Michalak JC, Addo F, Krook JE, Witzig TE, Schaefer PL, Mailliard JA. Tefferi A, et al. Among authors: geyer sm. Leukemia. 2001 Aug;15(8):1171-5. doi: 10.1038/sj.leu.2402172. Leukemia. 2001. PMID: 11480558 Clinical Trial.
A phase II study of bortezomib in the treatment of metastatic malignant melanoma.
Markovic SN, Geyer SM, Dawkins F, Sharfman W, Albertini M, Maples W, Fracasso PM, Fitch T, Lorusso P, Adjei AA, Erlichman C. Markovic SN, et al. Among authors: geyer sm. Cancer. 2005 Jun 15;103(12):2584-9. doi: 10.1002/cncr.21108. Cancer. 2005. PMID: 15887220 Free article. Clinical Trial.
Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival.
Cerhan JR, Wang S, Maurer MJ, Ansell SM, Geyer SM, Cozen W, Morton LM, Davis S, Severson RK, Rothman N, Lynch CF, Wacholder S, Chanock SJ, Habermann TM, Hartge P. Cerhan JR, et al. Among authors: geyer sm. Blood. 2007 Jun 15;109(12):5439-46. doi: 10.1182/blood-2006-11-058040. Epub 2007 Feb 27. Blood. 2007. PMID: 17327408 Free PMC article.
Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51.
Kurtz DM, Tschetter LK, Allred JB, Geyer SM, Kurtin PJ, Putnam WD, Rowland KM Jr, Wiesenfeld M, Soori GS, Tenglin RC, Bernath AM, Witzig TE. Kurtz DM, et al. Among authors: geyer sm. Leuk Lymphoma. 2007 Jul;48(7):1290-8. doi: 10.1080/10428190701355028. Leuk Lymphoma. 2007. PMID: 17613756 Clinical Trial.
124 results